HBV-IN-35

CAT: 0013-GTR19230928-01Size: 5 mgDry Ice: NoHazardous: No

1 / 1

CAT#:0013-GTR19230928-01Size:5 mg

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

Compound HBV-IN-35 (Compound 88) is a potent small molecule inhibitor of hepatitis B virus, demonstrating activity in vitro with EC50 values of 100 nM in mouse and 400 nM in human hepatocytes. This inhibitor is a valuable research tool for studying HBV replication and evaluating antiviral agents in both cellular and animal models.

Field of Research

Infectious Disease & Virology

Molecular Formula

C22H23F5N4O

Molecular Weight

454.44

Storage Conditions

-20°C

Notes

For research use only.

Related Products

Catalog	Name
GTR19191176-01	HBV-IN-4
GTR19186978-01	HBV-IN-21
GTR19186634-01	HBV-IN-16
GTR19186363-01	HBV-IN-9
GTR19186136-01	HBV-IN-17
GTR19185970-01	HBV-IN-12
GTR19185880-01	HBV-IN-7
GTR19184761-01	HBV-IN-8
GTR19184451-01	HBV-IN-20
GTR19239066-01	HBV-IN-48

Alternative Products

Catalog	Name
T78783-01	HBV-IN-35
ant-150	HBV
H1915-98G	Hepatitis B Surface Antigen PreS2 (HBV PreS2) discontinued. see H1910-35
P525235	HBV-C Protein (C-His, HBV)
LV1601	HBV(+) and HBV(-) noncancerous liver tissue array
BA1849-10	HBV-IN-37
601090020	Truenat™ HBV
FSD89784-01	HBV-IN-4
HY-146395	HBV-IN-23
HY-149435	HBV-IN-36

HBV-IN-35

Related Products

Alternative Products

Popular Products